期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
基于网络药理学探讨“红花-桃仁”药对防治冠心病的作用机制 被引量:7
1
作者 高源 季伟 +3 位作者 肖丹 刘井 彭丹冰 彭源 《世界科学技术-中医药现代化》 CSCD 北大核心 2019年第10期2180-2187,共8页
目的采用网络药理学的方法,筛选“红花-桃仁”药对防治冠心病的作用靶点,揭示“红花-桃仁”防治冠心病的中医配伍机制。方法通过查阅文献(PubMed、CNKI)、中药系统药理学数据库(TCMSP)检索“红花-桃仁”的所有化学成分,以ADME参数(OB≥... 目的采用网络药理学的方法,筛选“红花-桃仁”药对防治冠心病的作用靶点,揭示“红花-桃仁”防治冠心病的中医配伍机制。方法通过查阅文献(PubMed、CNKI)、中药系统药理学数据库(TCMSP)检索“红花-桃仁”的所有化学成分,以ADME参数(OB≥30%和DL≥0.15)及药效活性为标准,筛选“红花-桃仁”的活性化合物,然后通过BATMAN-TCM数据库,筛选活性化合物的作用靶点,建立靶点数据集;使用Cytoscape3.6.1软件构建“活性化合物-靶点-疾病”复杂网络关系图;运用STRING数据库、生物学信息注释数据库(DAVID)进行蛋白互作关系分析、基因本体(GO)功能富集分析和基于京都基因与基因组百科全书(KEGG)通路富集分析研究其防治冠心病的配伍机制。结果共检索出255个化合物,其中38个化合物作为活性化合物;共检索出718个作用靶点,通网络拓扑特征评价筛选出10个潜在作用靶点与药对防治冠心病的配伍机制最为密切,利用DAVID数据库对10个潜在作用靶点进行基因GO功能富集分析和KEGG通路富集分析,筛选出66个生物过程和18条信号通路参与“红花-桃仁”药对防治冠心病的作用。而与“红花-桃仁”药对防治冠心病最为密切的信号通路包括肿瘤坏死因子信号通路、疟疾、非洲锥虫病、NOD样受体信号通路等,同时其主要涉及的生物过程包括脂多糖介导的信号通路、序列特异性DNA结合转录因子活性的正调控、蛋白磷酸化的正调控、蛋白激酶B信号转导、一氧化氮生物合成过程的正调控等;其防治冠心病的机制主要是通过上调或下调这些生物过程和信号通路,发挥多成分、多靶点、多途径相须协同增效的生物学效应。结论网络药理学为揭示“红花-桃仁”防治冠心病的中医配伍机制提供了新的思路和方法,也为“红花-桃仁”药对的深入研究及开发利用提供了现代科学内涵。 展开更多
关键词 “红花-桃仁” 活性成分 冠心病 网络药理学 作用机制
下载PDF
桃仁红花煎治疗缺血性心脏病56例临床观察 被引量:7
2
作者 黎均铭 《实用中医内科杂志》 2016年第5期36-37,共2页
[目的]观察桃仁红花煎治疗缺血性心脏病疗效。[方法]使用前瞻性设计方法,56例门诊患者桃仁红花煎(桃仁12g,红花10g,郁金15g,丹参20g,青皮12g,赤芍20g,延胡索15g,薤白18g,甘草5g),1剂/d,水煎600mL,早晚口服。连续治疗14d为1疗程。观测临... [目的]观察桃仁红花煎治疗缺血性心脏病疗效。[方法]使用前瞻性设计方法,56例门诊患者桃仁红花煎(桃仁12g,红花10g,郁金15g,丹参20g,青皮12g,赤芍20g,延胡索15g,薤白18g,甘草5g),1剂/d,水煎600mL,早晚口服。连续治疗14d为1疗程。观测临床症状、心绞痛程度、不良反应。连续治疗3疗程,判定疗效。[结果]治愈16例,显效22例,有效10例,无效8例,总有效率85.70%。[结论]桃仁红花煎治疗缺血性心脏病,疗效满意,无严重不良反应,值得推广。 展开更多
关键词 缺血性心脏病 胸痹 心痛 桃仁红花 心绞痛程度 中医药治疗 临床观察
下载PDF
TRHH-herb pair prevents IL-1β-induced degeneration of endplate chondrocytes in vitro 被引量:12
3
作者 Kai Niu Chenguang Li +4 位作者 Song Yuan Lei Zhang Qi Shi Yongjun Wang Weichao Zheng 《Journal of Chinese Pharmaceutical Sciences》 CAS CSCD 2016年第8期590-597,共8页
The inflammatory cytokine interleukin-1 beta (IL-1β) plays a key role in the process of intervertebral disc degenera- tion (IVDD). In the present study, we aimed to evaluate the effect of pharmaco-serum of "Taor... The inflammatory cytokine interleukin-1 beta (IL-1β) plays a key role in the process of intervertebral disc degenera- tion (IVDD). In the present study, we aimed to evaluate the effect of pharmaco-serum of "Taoren-Honghua-herb pair" on IL-1β- induced chondrocyte degeneration in vitro. Taoren (Semen persicae) and Honghua (Safflower carthamus) were administered to the rats, and the pharmaco-serum was collected and prepared. Chondrocytes of the third passage, isolated from the rat's vertebral endplates, were treated by standard medium only (Group NC), IL-1β (Group IL) or combination of IL-1β and pharmaco-serum (Group TRHH). Cell proliferation and apoptosis were determined, and the expression of aggrecan, Col2ul, Coll0ul, IL-6 and SOX9 at the mRNA level in chondrocytes was quantified by real-time PCR. Immunohistochemistry staining of type II and X collagen and Safranine O staining were also used to evaluate the chondrocytes. Compared with the Group NC, IL-1β treatment inhibited the cell proliferation and induced the cell apoptosis (P〈0.05), and the expression of aggrecan, Col2αl and SOX9 at the mRNA level was down-regulated. In contrast, the expression of Coll0ul and IL-6 was up-regulated after IL-1β treatment (P〈0.05). Meanwhile, the immune-staining of type II collagen and Safranine O staining were decreased, while the staining of type X collagen was increased. Compared with the Group IL, cell proliferation was increased, and apoptosis of chondrocytes was decreased when cells were treated with the pharmaco-semm of TRHH-herb pair (P〈0.05). The expression of aggrecan, Col2cd and SOX9 at the mRNA level was up-regulated, while that of Coll0cd and IL-6 was down-regulated (P〈0.05). Saffanine O staining also showed increased positive staining (P〈0.05). Taken together, the treatment of pharmaco-serum of TRHH-herb pair could prevent endplate chondrocyte degeneration induced by IL-1β. 展开更多
关键词 Pharmaco-serum TRHH-herb pair DEGENERATION Chondrocyte Intervertebral discs
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部